Kewaunee Scientific (KEQU) sets Q2 FY2026 earnings date

Kewaunee Scientific Corporation filed a Form 8-K to let investors know when its next financial results will be issued.

Accepted by SEC EDGAR 11/26/2025 - 04:04 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Kewaunee Scientific Corporation filed a Form 8-K to let investors know when its next financial results will be issued. The company plans to release its second quarter fiscal 2026 earnings on December 10, 2025. This notice is an administrative update and does not include any financial results or guidance. The related earnings press release is identified as Exhibit 99.1 to the report.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kewaunee Scientific (KEQU) report Q2 fiscal 2026 earnings?

Kewaunee Scientific plans to release its second quarter fiscal 2026 earnings on December 10, 2025, as disclosed in this Form 8-K.

What is the purpose of this Kewaunee Scientific (KEQU) Form 8-K?

The Form 8-K announces the planned release date for Kewaunee Scientific's Q2 fiscal 2026 earnings and identifies the related press release as Exhibit 99.1.

Does this Kewaunee Scientific 8-K include actual earnings results?

No. This 8-K only states that Kewaunee Scientific plans to release its second quarter fiscal 2026 earnings on December 10, 2025; it does not contain financial results.

What exhibit is attached to the Kewaunee Scientific (KEQU) 8-K?

The filing lists Exhibit 99.1 as the press release of Kewaunee Scientific Corporation dated November 26, 2025, along with Exhibit 104 for the cover page interactive data file.

Which stock exchange lists Kewaunee Scientific common stock?

Kewaunee Scientific's common stock, with a par value of $2.50 per share and trading symbol KEQU, is listed on The Nasdaq Global Market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

KEWAUNEE SCIENTIFIC CORP /DE/FALSE000005552900000555292025-11-262025-11-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 26, 2025

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

Delaware

0-5286

38-0715562

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

2700 West Front Street

Statesville, NC 28677

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $2.50 par value

KEQU

The Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ☐

Item 8.01 Other Events

On November 26, 2025, Kewaunee Scientific Corporation announced that the Company plans to release its second quarter fiscal 2026 earnings on December 10, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press Release of Kewaunee Scientific Corporation dated November 26, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

						KEWAUNEE SCIENTIFIC CORPORATION                              (Registrant)
Date: November 26, 2025						By			/s/ Donald T. Gardner III
									Donald T. Gardner III
									Vice President, Finance
									Chief Financial Officer